Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Multiple congenital abnormalities? 9 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Multiple congenital abnormalities have been filed in association with GABAPENTIN (Gabapentin). This represents 0.0% of all adverse event reports for GABAPENTIN.

9
Reports of Multiple congenital abnormalities with GABAPENTIN
0.0%
of all GABAPENTIN reports
4
Deaths
1
Hospitalizations

How Dangerous Is Multiple congenital abnormalities From GABAPENTIN?

Of the 9 reports, 4 (44.4%) resulted in death, 1 (11.1%) required hospitalization.

Is Multiple congenital abnormalities Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Product use in unapproved indication (4,919) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791)

What Other Drugs Cause Multiple congenital abnormalities?

OXYCODONE (173) ACETAMINOPHEN\HYDROCODONE (107) ACETAMINOPHEN\OXYCODONE (102) ONDANSETRON (96) HYDROMORPHONE (95) MORPHINE (88) TRAMADOL (68) VALPROATE (59) BUPRENORPHINE (58) LAMOTRIGINE (45)

Which GABAPENTIN Alternatives Have Lower Multiple congenital abnormalities Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Multiple congenital abnormalities Reports All Drugs Causing Multiple congenital abnormalities GABAPENTIN Demographics